Property Solutions Acquisition Corp. II (PSAG) 10-Q 18 Nov 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 18, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2022
Entity File Number	001-40087
Entity Registrant Name	PROPERTY SOLUTIONS ACQUISITION CORP. II
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3851769
Entity Address, Address Line One	654 Madison Avenue, Suite 1009
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10065
City Area Code	646
Local Phone Number	502-9845
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001833235
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Amendment Flag	false
Units, each consisting of one share of Class A Common Stock and one-fourth of one Warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share ofClass A Common Stock, and one-fourth of one Warrant to acquire oneshare of Class A Common Stock
Trading Symbol	PSAGU
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		3,334,749
Common Class A [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	PSAG
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		29,504,251
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole Warrantexercisable for one share of Class ACommon Stock at an exercise price of $11.50
Trading Symbol	PSAGW
Security Exchange Name	NASDAQ
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		7,925,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash	$ 10,582	$ 531,984
Prepaid expenses- Short-term	105,517	209,207
Total Current Assets	116,099	741,191
Prepaid expenses- Long-term	0	34,590
Marketable securities held in Trust Account	318,684,239	317,025,510
TOTAL ASSETS	318,800,338	317,801,291
Current liabilities
Accrued expenses	222,028	285,139
Income taxes payable	355,835	0
Total Current Liabilities	577,863	285,139
Warrant Liability	488,085	4,629,712
Deferred underwriting fee payable	11,095,000	11,095,000
Total Liabilities	11,985,498	16,009,851
Commitments
Stockholders' Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(11,700,133)	(15,209,467)
Total Stockholders' Deficit	(11,699,226)	(15,208,560)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	318,800,338	317,801,291
Class A common stock subject to redemption
Current liabilities
Class A common stock, $0.0001 par value, subject to possible redemption, 31,700,000 shares at redemption value of approximately $10.04 and $10.00 at September 30, 2022 and December 31, 2021, respectively	318,338,616	317,000,000
Class A common stock not subject to redemption
Stockholders' Deficit
Common stock	114	114
Class B Common Stock
Stockholders' Deficit
Common stock	$ 793	$ 793

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Common Stock
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	100,000,000	100,000,000
Class A common stock subject to redemption
Temporary Equity, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Temporary equity, shares outstanding	31,700,000	31,700,000
Temporary equity, redemption value per share	$ 10.04	$ 10
Class A common stock not subject to redemption
Common shares, shares issued	1,139,000	1,139,000
Common shares, shares outstanding	1,139,000	1,139,000
Class B Common Stock
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	10,000,000	10,000,000
Common shares, shares issued	7,925,000	7,925,000
Common shares, shares outstanding	7,925,000	7,925,000

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Formation and operational costs	$ 227,288	$ 313,026	$ 938,389	$ 619,403
Loss from operations	(227,288)	(313,026)	(938,389)	(619,403)
Other income:
Interest earned on marketable securities held in Trust Account	1,297,528	4,080	1,973,888	20,391
Unrealized gain on marketable securities held in Trust Account	181,283	0	26,659	0
Representative Share Transaction Costs				(68,476)
Change in fair value of overallotment liability			0	196,475
Change in fair value of warrant liability	81,348	4,230,070	4,141,627	1,626,950
Transaction costs allocable to warrant liability	0	0	0	(402,827)
Total other income, net	1,560,159	4,234,150	6,142,174	1,372,513
Income before provision for income taxes	1,332,871	3,921,124	5,203,785	753,110
Provision for income taxes	(203,138)		(355,835)
Net income	$ 1,129,733	$ 3,921,124	$ 4,847,950	$ 753,110
Class A Common Stock
Other income:
Weighted Average Number of Shares Outstanding, Basic	32,839,000	32,839,000	32,839,000	24,779,612
Weighted Average Number of Shares Outstanding, Diluted	32,839,000	32,839,000	32,839,000	24,779,612
Earnings Per Share, Basic	$ 0.03	$ 0.10	$ 0.12	$ 0.02
Earnings Per Share, Diluted	$ 0.03	$ 0.10	$ 0.12	$ 0.02
Class B Common Stock
Other income:
Weighted Average Number of Shares Outstanding, Basic	7,925,000	7,925,000	7,925,000	7,820,696
Weighted Average Number of Shares Outstanding, Diluted	7,925,000	7,925,000	7,925,000	7,820,696
Earnings Per Share, Basic	$ 0.03	$ 0.10	$ 0.12	$ 0.02
Earnings Per Share, Diluted	$ 0.03	$ 0.10	$ 0.12	$ 0.02

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Class A Common Stock Common Stock	Class B Common Stock Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2020	$ 0	$ 863	$ 24,137	$ (1,540)	$ 23,460
Balance at the beginning (in shares) at Dec. 31, 2020	0	8,625,000
Increase (Decrease) in Stockholders' Equity
Sale of 839,000 Private Placement Units	$ 84		8,203,648	0	8,203,732
Sale of 839,000 Private Placement Units (in shares)	839,000
Issuance of Representative Shares	$ 30		2,999,970	0	3,000,000
Issuance of Representative Shares (in shares)	300,000
Forfeiture of Founder Shares		$ (70)	70	0
Forfeiture of Founder Shares (in Shares)		(700,000)
Remeasurement to amount subject to redemption			(11,227,825)	(16,690,878)	(27,918,703)
Net income (loss)			0	(396,332)	(396,332)
Balance at the end at Mar. 31, 2021	$ 114	$ 793	0	(17,088,750)	(17,087,843)
Balance at the end (in shares) at Mar. 31, 2021	1,139,000	7,925,000
Balance at the beginning at Dec. 31, 2020	$ 0	$ 863	24,137	(1,540)	23,460
Balance at the beginning (in shares) at Dec. 31, 2020	0	8,625,000
Increase (Decrease) in Stockholders' Equity
Issuance of Representative Shares					3,000,000
Forfeiture of Founder Shares					(70)
Remeasurement to amount subject to redemption					27,918,703
Net income (loss)					753,110
Balance at the end at Sep. 30, 2021	$ 114	$ 793	0	(16,067,307)	(16,066,400)
Balance at the end (in shares) at Sep. 30, 2021	1,139,000	7,925,000
Balance at the beginning at Mar. 31, 2021	$ 114	$ 793	0	(17,088,750)	(17,087,843)
Balance at the beginning (in shares) at Mar. 31, 2021	1,139,000	7,925,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)			0	(2,899,681)	(2,899,681)
Balance at the end at Jun. 30, 2021	$ 114	$ 793	0	(19,988,431)	(19,987,524)
Balance at the end (in shares) at Jun. 30, 2021	1,139,000	7,925,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)			0	3,921,124	3,921,124
Balance at the end at Sep. 30, 2021	$ 114	$ 793	$ 0	(16,067,307)	(16,066,400)
Balance at the end (in shares) at Sep. 30, 2021	1,139,000	7,925,000
Balance at the beginning at Dec. 31, 2021	$ 114	$ 793		(15,209,467)	(15,208,560)
Balance at the beginning (in shares) at Dec. 31, 2021	1,139,000	7,925,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)				1,610,657	1,610,657
Balance at the end at Mar. 31, 2022	$ 114	$ 793		(13,598,810)	(13,597,903)
Balance at the end (in shares) at Mar. 31, 2022	1,139,000	7,925,000
Balance at the beginning at Dec. 31, 2021	$ 114	$ 793		(15,209,467)	(15,208,560)
Balance at the beginning (in shares) at Dec. 31, 2021	1,139,000	7,925,000
Increase (Decrease) in Stockholders' Equity
Issuance of Representative Shares					$ 870
Issuance of Representative Shares (in shares)					300,000
Net income (loss)					$ 4,847,950
Balance at the end at Sep. 30, 2022	$ 114	$ 793		(11,700,133)	(11,699,226)
Balance at the end (in shares) at Sep. 30, 2022	1,139,000	7,925,000
Balance at the beginning at Mar. 31, 2022	$ 114	$ 793		(13,598,810)	(13,597,903)
Balance at the beginning (in shares) at Mar. 31, 2022	1,139,000	7,925,000
Increase (Decrease) in Stockholders' Equity
Remeasurement to amount subject to redemption				(265,640)	(265,640)
Net income (loss)				2,107,560	2,107,560
Balance at the end at Jun. 30, 2022	$ 114	$ 793		(11,756,890)	(11,755,983)
Balance at the end (in shares) at Jun. 30, 2022	1,139,000	7,925,000
Increase (Decrease) in Stockholders' Equity
Remeasurement to amount subject to redemption				(1,072,976)	(1,072,976)
Net income (loss)				1,129,733	1,129,733
Balance at the end at Sep. 30, 2022	$ 114	$ 793		$ (11,700,133)	$ (11,699,226)
Balance at the end (in shares) at Sep. 30, 2022	1,139,000	7,925,000

CONDENSED STATEMENTS OF CHANG_2

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical)	Mar. 31, 2021 shares
Private Placement | Private Placement Warrants
Sale of Private Placement Units (in shares)	839,000

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net income	$ 4,847,950	$ 753,110
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(1,973,888)	(20,391)
Unrealized gain on marketable securities held in Trust Account	(26,659)	0
Change in fair value of warrant liability	(4,141,627)	(1,626,950)
Change in fair value of over-allotment liability	0	(196,475)
Transaction costs allocable to representative shares	0	68,476
Transaction costs allocable to warrant liabilities	0	402,827
Changes in operating assets and liabilities:
Prepaid expenses	138,280	(311,182)
Accrued expenses	(63,111)	191,548
Income taxes payable	355,835
Net cash used in operating activities	(863,220)	(739,037)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	0	(317,000,000)
Cash withdrawn from Trust Account to pay franchise and income taxes	341,818
Net cash provided by (used in) investing activities	341,818	(317,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	0	310,660,000
Proceeds from sale of Private Placement Units	0	8,390,000
Proceeds from issuance of Representative Shares	0	870
Repayment of promissory note-related party	0	(200,000)
Payment of offering costs	0	(634,441)
Net cash provided by financing activities	0	318,216,429
Net Change in Cash	(521,402)	477,392
Cash - Beginning of period	531,984	165,000
Cash - End of period	10,582	642,392
Non-Cash investing and financing activities:
Offering costs included in accrued offering costs	0	358,417
Initial classification of Public Warrants	0	7,053,250
Initial classification of Private Warrants		186,678
Initial classification of over-allotment liability		294,078
Deferred underwriting fee payable	0	11,095,000
Forfeiture of Founder Shares		(70)
Remeasurement of common stock subject to possible redemption	$ 1,338,616	$ 0

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	9 Months Ended
	Sep. 30, 2022
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	​ NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Property Solutions Acquisition Corp. II (the “Company”) was incorporated in Delaware on October 29, 2020. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022 relates to the Company’s formation, initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s Initial Public Offering was declared effective on March 3, 2021. On March 8, 2021, the Company consummated the Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 805,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Property Solutions Acquisition Sponsor II, LLC (the “Sponsor”) and EarlyBirdCapital, Inc. (“EarlyBirdCapital”), generating gross proceeds of $8,050,000, which is described in Note 5. On March 12, 2021, the underwriters partially exercised their over-allotment option (see Note 4), resulting in an additional 1,700,000 Units issued for an aggregate amount of $17,000,000. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 34,000 Private Placement Units at $10.00 per Private Placement Unit, generating total proceeds of $340,000 (see Note 5). Transaction costs amounted to $18,140,741, consisting of $6,340,000 of underwriting fees, $11,095,000 of deferred underwriting fees and $705,741 of other offering costs. Following the closing of the Initial Public Offering on March 8, 2021 and the partial exercise of the underwriter’s over-allotment option on March 12, 2021, an amount of $317,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”), and are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully complete a Business Combination. The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and EarlyBirdCapital have agreed to vote their Founder Shares (as defined in Note 6), Representative Shares (as defined in Note 7), Private Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering (a) in favor of approving a Business Combination and (b) not to convert any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, public stockholders may elect to redeem their Public Shares, irrespective of whether they vote for or against the proposed Business Combination. The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares, Private Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until March 8, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor and EarlyBirdCapital have agreed to waive their liquidation rights with respect to the Founder Shares, Representative Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or EarlyBirdCapital acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed to waive its rights to the deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern As of September 30, 2022, the Company had $10,582 in its operating bank accounts and working capital deficit of $76,141, when accounting for the Company’s ability to use interest income to pay towards tax liabilities. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company will need to raise further additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. In addition to the loan commitment described herein, the Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through March 8, 2023, the Company’s liquidation date, and/or through twelve months from the issuance of these financial statements. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

REVISION OF PREVIOUSLY ISSUED F

REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	9 Months Ended
	Sep. 30, 2022
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS In connection with the preparation of the Company’s financial statements as of December 31, 2021, Management identified errors made in its historical financial statements where, at the closing of the Company’s Initial Public Offering, the Company did not record a liability related to the underwriter’s option to exercise their over-allotment. Additionally, the Company did not appropriately apply the correct equity presentation or allocation of offering costs related to the Company’s issued representative shares, furthermore, the Company has revised operating costs for the nine months ended September 30, 2021, due to a reclassification of legal expenses between quarters. These errors were recorded and presented within the financial statements as of December 31, 2021. This revision note is presenting the changes from the previously reported balances to the adjusted balances as of and for the nine months ended September 30, 2021 for comparative purposes of these condensed financial statements. These errors resulted in an adjustment to the net income. The impact of the revision on the Company’s financial statements is reflected in the following table. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Statement of Operations for the Nine Months Ended September 30, 2021 ​ Reported ​ Adjustment ​ As Revised Change in fair value of over-allotment liability ​ $ — ​ $ 196,475 ​ $ 196,475 Transaction costs allocable to representative shares ​ $ — ​ $ (68,476) ​ $ (68,476) Net Loss ​ $ 625,111 ​ $ 127,999 ​ $ 753,110 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Statement of Stockholders’ Deficit for the Nine Months Ended September 30, 2021 ​ Reported ​ Adjustment ​ As Revised Issuance of representative shares ​ ​ 870 ​ ​ 2,999,130 ​ ​ 3,000,000 Remeasurement to amount subject to redemption ​ ​ (24,791,574) ​ ​ 3,127,129 ​ $ (27,918,703) Net loss ​ $ 625,111 ​ $ 127,999 ​ $ 753,110 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Statement of Cashflows for the Nine Months Ended September 30, 2021 ​ Reported ​ Adjustment ​ As Revised Change in fair value of over-allotment liability ​ $ — ​ $ (196,475) ​ $ (196,475) Transaction costs allocable to representative shares ​ $ — ​ $ 68,476 ​ $ 68,476 Net loss ​ $ 625,111 ​ $ 127,999 ​ $ 753,110 Initial classification of over-allotment Liability ​ $ — ​ $ 294,708 ​ $ 294,078 ​

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 18, 2022. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates require management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021. Marketable Securities Held in Trust Account At September 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. Warrant Liabilities The Company accounts for the Public Warrants (as defined in Note 4) and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Binomial lattice model. Offering Costs Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities and representative shares were expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity. Offering costs amounted to $705,741, of which $234,438 was charged to temporary equity and $471,303 was expensed as incurred in the statements of operation upon the completion of the Initial Public Offering. In addition, the underwriter was paid $6,340,000 at closing of the Initial Public Offering and a deferred underwriting fee of $11,095,000 was charged against equity and presented on the accompanying consolidated balance sheets. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 317,000,000 Less: ​ Proceeds allocated to Public Warrants ​ ​ (7,053,250) Class A common stock issuance costs ​ ​ (20,865,453) Plus: ​ ​ Remeasurement to amount subject to redemption ​ ​ 27,918,703 Class A common stock subject to possible redemption, December 31, 2021 ​ ​ 317,000,000 Plus: ​ ​ ​ Remeasurement to amount subject to redemption ​ ​ 1,338,616 Class A common stock subject to possible redemption, September 30, 2022 ​ $ 318,338,616 ​ Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it. The Company’s effective tax rate was 15.24% and 0.00% for the three months ended September 30, 2022 and 2021, respectively, and 6.84% and 0.00% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022 and 2021, due to changes in fair value in warrant liability, and the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 8,134,750 Class A common stock in the aggregate. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common stock is the same as basic net loss per common stock for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ September 30, 2022 September 30, 2021 ​ September 30, 2022 September 30, 2021 ​ Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income per ordinary share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income, as adjusted ​ $ 910,100 ​ $ 219,633 ​ $ 3,158,811 ​ $ 762,313 ​ $ 3,905,452 ​ $ 942,498 ​ $ 572,441 ​ $ 180,669 Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary share outstanding ​ ​ 32,839,000 ​ ​ 7,925,000 ​ ​ 32,839,000 ​ ​ 7,925,000 ​ ​ 32,839,000 ​ ​ 7,925,000 ​ ​ 24,779,612 ​ ​ 7,820,696 Basic and diluted net income per ordinary share ​ $ 0.03 ​ $ 0.03 ​ $ 0.10 ​ $ 0.10 ​ $ 0.12 ​ $ 0.12 ​ $ 0.02 ​ $ 0.02 ​ Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, excluding the Warrant liability (see Note 10). Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt –debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”) The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

PUBLIC OFFERING

PUBLIC OFFERING	9 Months Ended
	Sep. 30, 2022
PUBLIC OFFERING
PUBLIC OFFERING	NOTE 4. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 31,700,000 Units, inclusive of 1,700,000 Units sold to the underwriters on March 12, 2021 upon the underwriters’ election to partially exercise their over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one share of the Company’s Class A common stock and one

PRIVATE PLACEMENT

PRIVATE PLACEMENT	9 Months Ended
	Sep. 30, 2022
PRIVATE PLACEMENT.
PRIVATE PLACEMENT	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor and EarlyBirdCapital purchased an aggregate of 805,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement. The Sponsor purchased 655,000 Private Placement Units and EarlyBirdCapital purchased 150,000 Private Placement Units. The Sponsor agreed to purchase up to an additional 67,500 Private Placement Units and EarlyBirdCapital agreed to purchase up to an additional 22,500 Private Placement Units if the over-allotment option was exercised in full. On March 12, 2021, the Sponsor and EarlyBirdCapital purchased 34,000 Private Placement Units for an additional aggregate purchase price of $340,000 in connection with the partial exercise of the underwriter’s over-allotment option. Each Private Placement Unit consists of one share of Class A common stock (“Private Share”) and one

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2022
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On November 10, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 5,750,000 shares of Class B common stock (the “Founder Shares”). On February 4, 2021, the Company effectuated a 1:1.25 stock split of its Class B common stock and on March 3, 2021, the Company effectuated a 1.2 stock split of its Class B common stock, which resulted in an aggregate of 8,625,000 Founder Shares outstanding. The Founder Shares include an aggregate of up to 700,000 shares that remain subject to forfeiture by the Sponsor following the underwriters’ election to partially exercise their over-allotment option (see Note 7), so that the Sponsor and the Company’s independent directors will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering and excluding the Private Shares). As a result of the underwriters’ election to partially exercise their over-allotment option, a total of 425,000 Founder Shares are no longer subject to forfeiture and 700,000 Founder Shares were forfeited resulting in an aggregate of 7,925,000 Founder Shares outstanding. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the reported closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property. On February 18, 2021, the sponsor transferred 15,000 shares common for a The transfer of the Founders Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The value of the transferred Founders Shares on the grant date of February 18, 2021 was $6.91 per share for a total aggregate value of $373,140. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of September 30, 2022, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. Administrative Services Agreement The Company agreed, commencing on March 3, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Company’s executive officers a total of $10,000 per month for office space and general and administrative services. For the three months and nine months ended September 30, 2022, the Company incurred $30,000 and $90,000 in fees for these services, respectively, of which $10,000 of such amount is included in accrued expenses in the accompanying balance sheets. For the three months and nine months ended September 30, 2021, the Company incurred $30,000 and $70,000 in fees for these services, respectively. As of December 31, 2021 there was $10,000 of such fees included in accounts payable and accrued expenses. Promissory Note — Related Party On November 10, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2021, (ii) the consummation of the Initial Public Offering or (ii) the date on which the Company determines not to proceed with the Initial Public Offering. As of September 30, 2022 and December 31, 2021, there was no amount outstanding under the Promissory Note. The outstanding amount of $200,000 was repaid at the closing of the Initial Public Offering on March 8, 2021. Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of September 30, 2022 or December 31, 2021, no amounts have been withdrawn or are outstanding relating to these Working Capital Loans.

COMMITMENTS

COMMITMENTS	9 Months Ended
	Sep. 30, 2022
COMMITMENTS
COMMITMENTS	NOTE 7. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on March 3, 2021, the holders of the Founder Shares and Representative Shares, as well as the holders of the Private Placement Units and any units that may be issued in payment of Working Capital Loans made to the Company, have registration rights to require the Company to register for resale of any of the Company’s securities held by them. The holder of these securities and the Sponsor are entitled to make unlimited demands that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital may only make a demand on one occasion and only during the five-year period beginning on the effective date of the Initial Public Offering. In addition, EarlyBirdCapital may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements. However, the registration and stockholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The registration rights and stockholder agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less the underwriting discounts and commissions. On March 12, 2021, the underwriter’s election to partially exercise the over-allotment option to purchase an additional 1,700,000 Units and forfeited their option to purchase an additional 2,800,000 Units. The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,500,000 in the aggregate (or $12,075,000 in the aggregate if the underwriters’ over-allotment option is exercised in full). The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2022
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 8. STOCKHOLDERS’ DEFICIT Preferred Stock issued Class A Common Stock The Company is authorized to issue up to 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. At September 30, 2022 and December 31, 2021, there were 32,839,000 shares of Class A common stock issued and outstanding, including 31,700,000 Class A common stock subject to possible redemption which are presented as temporary equity. Class B Common Stock The Company is authorized to issue up to 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At September 30, 2022 and December 31, 2021, there were 7,925,000 shares of common stock issued and outstanding. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as otherwise required by law. The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in this prospectus and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the Sponsor agrees to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (after giving effect to any redemptions of shares of Class A common stock by public stockholders, excluding any Private Placement Units issued to the Sponsor, officers or directors upon conversion of Working Capital Loans). The Sponsor may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

WARRANTS

WARRANTS	9 Months Ended
	Sep. 30, 2022
WARRANTS.
WARRANTS	NOTE 9. WARRANTS Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the warrants. The Company will use its reasonable best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the ninetieth day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Redemption of warrants when the price per Class A common stock equals or exceeds $18.00 . ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days ’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and ● if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per Class A common stock equals or exceeds $ 10.00 . ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that during such 30 day period holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of our shares of Class A common stock (as defined below) except as otherwise described below; provided, further, that if the warrants are not exercised on a cashless basis or otherwise during such 30 day period, the Company shall redeem such warrants for $0.10 per share; ● if, and only if, the Private Placement Warrants are also concurrently called for redemption at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and ● if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 50% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Representative Shares The Company issued 300,000 shares of Class A common stock (the “Representative Shares”) to the designees of EarlyBirdCapital for an aggregate purchase price of $870. The Company accounted for the Representative Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders’ equity. The Company estimated the fair value of the Representative Shares to be $3,000,000, based upon the price of the Units sold in the Initial Public Offering. The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their conversion rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period. The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(e)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2022
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 10. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Description ​ Level 2022 2021 Assets: ​ ​ Marketable securities held in Trust Account 1 ​ $ 318,684,239 ​ $ 317,025,510 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ Warrant Liability - Private Placement Warrants ​ 3 ​ $ 12,585 ​ $ 119,375 Warrant Liability - Public Warrants 1 ​ $ 475,500 ​ $ 4,510,337 ​ The Public Warrants and Private Placement Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our accompanying September 30, 2022 and December 31, 2021 condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations. Initial Measurement The Company established the initial fair value for the Public and Private Placement Warrants on March 8, 2021, the date of the Company’s Initial Public Offering, using a binomial lattice model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A common stock and one Subsequent Measurement The warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of September 30, 2022 is classified as Level 1 due to the use of an observable market quote in an active market. The subsequent measurement of the Private Placement Warrants was calculated using a Black Scholes model which is considered a Level 3 measurement. The key inputs into the binomial lattice model for the Private Placement Warrants were as follows at September 30, 2022 and December 31, 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ Input 2022 2021 ​ Risk-free interest rate ​ 4.12 % ​ 1.19 % Effective expiration date ​ 06/06/2024 ​ ​ 7/23/2026 ​ Dividend yield ​ ​ 0.00 % 0.00 % Expected volatility ​ ​ 6.4 % 12.1 % Exercise price ​ $ 11.50 ​ $ 11.50 ​ Unit Price ​ $ 9.81 ​ $ 9.71 ​ ​ As of September 30, 2022 and December 31, 2021, the aggregate values of the Private Placement Warrants were $0.01 million and $0.12 million, respectively. The following table presents the changes in the fair value of Level 3 warrant liabilities for the three months and nine months ended September 30, 2022: ​ ​ ​ ​ ​ ​ Private Placement ​ ​ Warrant Liability Fair value as of December 31, 2021 ​ $ 119,375 Change in fair value ​ (50,471) Fair value as of March 31, 2022 ​ ​ 68,904 Change in fair value ​ ​ (54,221) Fair value as of June 30, 2022 ​ ​ 14,683 Change in fair value ​ ​ (2,098) Fair value as of September 30, 2022 ​ $ 12,585 ​ The following table presents the changes in the fair value of Level 3 warrant liabilities for the three months and nine months ended September 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Private Placement ​ Public ​ Warrant Liability Warrant Liability Fair value as of January 1, 2021 ​ $ — ​ $ — Issuance of warrants on March 8, 2021 (IPO) ​ 179,113 ​ 6,675,000 Issuance of warrants on March 12, 2021 (Over Allotment) ​ 7,565 ​ 378,250 Change in fair value ​ (12,585) ​ (475,500) Fair value as of March 31, 2021 ​ ​ 174,903 ​ ​ 6,577,750 Change in fair value ​ ​ 79,705 ​ ​ 3,011,500 Transfer from Level 3 to Level 1 ​ ​ — ​ ​ (9,589,250) Fair value as of June 30, 2021 ​ ​ 253,798 ​ ​ — Change in fair value ​ ​ (109,070) ​ ​ — Fair value as of September 30, 2021 ​ $ 144,728 ​ $ — ​ Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. For the three and nine months ended September 30, 2022, there were no transfers from Level 3 measurements. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the three and nine months ended September 30, 2021 was $9,589,250.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2022
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 18, 2022. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates require management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At September 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.
Warrant Liability	Warrant Liabilities The Company accounts for the Public Warrants (as defined in Note 4) and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Binomial lattice model.
Offering Costs	Offering Costs Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities and representative shares were expensed as incurred in the statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity. Offering costs amounted to $705,741, of which $234,438 was charged to temporary equity and $471,303 was expensed as incurred in the statements of operation upon the completion of the Initial Public Offering. In addition, the underwriter was paid $6,340,000 at closing of the Initial Public Offering and a deferred underwriting fee of $11,095,000 was charged against equity and presented on the accompanying consolidated balance sheets.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 317,000,000 Less: ​ Proceeds allocated to Public Warrants ​ ​ (7,053,250) Class A common stock issuance costs ​ ​ (20,865,453) Plus: ​ ​ Remeasurement to amount subject to redemption ​ ​ 27,918,703 Class A common stock subject to possible redemption, December 31, 2021 ​ ​ 317,000,000 Plus: ​ ​ ​ Remeasurement to amount subject to redemption ​ ​ 1,338,616 Class A common stock subject to possible redemption, September 30, 2022 ​ $ 318,338,616 ​
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it. The Company’s effective tax rate was 15.24% and 0.00% for the three months ended September 30, 2022 and 2021, respectively, and 6.84% and 0.00% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022 and 2021, due to changes in fair value in warrant liability, and the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) per Common Share	Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 8,134,750 Class A common stock in the aggregate. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common stock is the same as basic net loss per common stock for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ September 30, 2022 September 30, 2021 ​ September 30, 2022 September 30, 2021 ​ Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income per ordinary share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income, as adjusted ​ $ 910,100 ​ $ 219,633 ​ $ 3,158,811 ​ $ 762,313 ​ $ 3,905,452 ​ $ 942,498 ​ $ 572,441 ​ $ 180,669 Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary share outstanding ​ ​ 32,839,000 ​ ​ 7,925,000 ​ ​ 32,839,000 ​ ​ 7,925,000 ​ ​ 32,839,000 ​ ​ 7,925,000 ​ ​ 24,779,612 ​ ​ 7,820,696 Basic and diluted net income per ordinary share ​ $ 0.03 ​ $ 0.03 ​ $ 0.10 ​ $ 0.10 ​ $ 0.12 ​ $ 0.12 ​ $ 0.02 ​ $ 0.02
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, excluding the Warrant liability (see Note 10).
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt –debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”) The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

REVISION OF PREVIOUSLY ISSUED_2

REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	9 Months Ended
	Sep. 30, 2022
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Schedule of impact of revision on financial statements	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Statement of Operations for the Nine Months Ended September 30, 2021 ​ Reported ​ Adjustment ​ As Revised Change in fair value of over-allotment liability ​ $ — ​ $ 196,475 ​ $ 196,475 Transaction costs allocable to representative shares ​ $ — ​ $ (68,476) ​ $ (68,476) Net Loss ​ $ 625,111 ​ $ 127,999 ​ $ 753,110 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Statement of Stockholders’ Deficit for the Nine Months Ended September 30, 2021 ​ Reported ​ Adjustment ​ As Revised Issuance of representative shares ​ ​ 870 ​ ​ 2,999,130 ​ ​ 3,000,000 Remeasurement to amount subject to redemption ​ ​ (24,791,574) ​ ​ 3,127,129 ​ $ (27,918,703) Net loss ​ $ 625,111 ​ $ 127,999 ​ $ 753,110 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ Statement of Cashflows for the Nine Months Ended September 30, 2021 ​ Reported ​ Adjustment ​ As Revised Change in fair value of over-allotment liability ​ $ — ​ $ (196,475) ​ $ (196,475) Transaction costs allocable to representative shares ​ $ — ​ $ 68,476 ​ $ 68,476 Net loss ​ $ 625,111 ​ $ 127,999 ​ $ 753,110 Initial classification of over-allotment Liability ​ $ — ​ $ 294,708 ​ $ 294,078

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of Class A common stock reflected in the condensed balance sheet	​ ​ ​ ​ ​ Gross proceeds $ 317,000,000 Less: ​ Proceeds allocated to Public Warrants ​ ​ (7,053,250) Class A common stock issuance costs ​ ​ (20,865,453) Plus: ​ ​ Remeasurement to amount subject to redemption ​ ​ 27,918,703 Class A common stock subject to possible redemption, December 31, 2021 ​ ​ 317,000,000 Plus: ​ ​ ​ Remeasurement to amount subject to redemption ​ ​ 1,338,616 Class A common stock subject to possible redemption, September 30, 2022 ​ $ 318,338,616
Schedule of calculation of basic and diluted net income (loss) per common share	The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ September 30, 2022 September 30, 2021 ​ September 30, 2022 September 30, 2021 ​ Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income per ordinary share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income, as adjusted ​ $ 910,100 ​ $ 219,633 ​ $ 3,158,811 ​ $ 762,313 ​ $ 3,905,452 ​ $ 942,498 ​ $ 572,441 ​ $ 180,669 Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary share outstanding ​ ​ 32,839,000 ​ ​ 7,925,000 ​ ​ 32,839,000 ​ ​ 7,925,000 ​ ​ 32,839,000 ​ ​ 7,925,000 ​ ​ 24,779,612 ​ ​ 7,820,696 Basic and diluted net income per ordinary share ​ $ 0.03 ​ $ 0.03 ​ $ 0.10 ​ $ 0.10 ​ $ 0.12 ​ $ 0.12 ​ $ 0.02 ​ $ 0.02

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2022
FAIR VALUE MEASUREMENTS
Schedule of Company's assets that are measured at fair value on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Description ​ Level 2022 2021 Assets: ​ ​ Marketable securities held in Trust Account 1 ​ $ 318,684,239 ​ $ 317,025,510 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ Warrant Liability - Private Placement Warrants ​ 3 ​ $ 12,585 ​ $ 119,375 Warrant Liability - Public Warrants 1 ​ $ 475,500 ​ $ 4,510,337
Schedule of initial and subsequent measurement of key inputs	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, ​ December 31, ​ Input 2022 2021 ​ Risk-free interest rate ​ 4.12 % ​ 1.19 % Effective expiration date ​ 06/06/2024 ​ ​ 7/23/2026 ​ Dividend yield ​ ​ 0.00 % 0.00 % Expected volatility ​ ​ 6.4 % 12.1 % Exercise price ​ $ 11.50 ​ $ 11.50 ​ Unit Price ​ $ 9.81 ​ $ 9.71 ​
Schedule of change in the fair value of the warrant liabilities	​ ​ ​ ​ ​ ​ Private Placement ​ ​ Warrant Liability Fair value as of December 31, 2021 ​ $ 119,375 Change in fair value ​ (50,471) Fair value as of March 31, 2022 ​ ​ 68,904 Change in fair value ​ ​ (54,221) Fair value as of June 30, 2022 ​ ​ 14,683 Change in fair value ​ ​ (2,098) Fair value as of September 30, 2022 ​ $ 12,585 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Private Placement ​ Public ​ Warrant Liability Warrant Liability Fair value as of January 1, 2021 ​ $ — ​ $ — Issuance of warrants on March 8, 2021 (IPO) ​ 179,113 ​ 6,675,000 Issuance of warrants on March 12, 2021 (Over Allotment) ​ 7,565 ​ 378,250 Change in fair value ​ (12,585) ​ (475,500) Fair value as of March 31, 2021 ​ ​ 174,903 ​ ​ 6,577,750 Change in fair value ​ ​ 79,705 ​ ​ 3,011,500 Transfer from Level 3 to Level 1 ​ ​ — ​ ​ (9,589,250) Fair value as of June 30, 2021 ​ ​ 253,798 ​ ​ — Change in fair value ​ ​ (109,070) ​ ​ — Fair value as of September 30, 2021 ​ $ 144,728 ​ $ —

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)			9 Months Ended
	Mar. 12, 2021 USD ($) $ / shares shares	Mar. 08, 2021 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) item $ / shares	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Dec. 03, 2021 USD ($)	Mar. 31, 2021 shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price per unit | $ / shares	$ 10
Proceeds from sale of Private Placement Units			$ 0	$ 8,390,000
Transaction costs	$ 18,140,741
Underwriting fees	6,340,000					$ 6,340,000
Deferred underwriting fee payable	11,095,000		$ 11,095,000		$ 11,095,000	11,095,000
Other offering costs	705,741					$ 705,741
Condition for future business combination number of businesses minimum | item			1
Payments for investment of cash in Trust Account	$ 317,000,000		$ 0	$ 317,000,000
Condition for future business combination use of proceeds percentage			80
Condition for future business combination threshold percentage ownership			50
Condition for future business combination threshold net tangible assets			$ 5,000,001
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)			100%
Redemption period upon closure			10 days
Operating bank accounts			$ 10,582
Working capital			$ (76,141)
Initial Public Offering
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of units sold | shares		30,000,000
Purchase price per unit | $ / shares	$ 10	$ 10	$ 10
Proceeds from issuance of initial public offering		$ 300,000,000
Private Placement
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Purchase price per unit | $ / shares	$ 10
Proceeds from issuance of initial public offering	$ 340,000
Sale of an additional Private Placement Units | shares	34,000
Private Placement | Private Placement Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of Private Placement Units (in shares) | shares							839,000
Private Placement | Early Bird Capital | Private Placement Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of Private Placement Units (in shares) | shares		805,000
Price of warrant (in dollars per share) | $ / shares		$ 10
Proceeds from sale of Private Placement Units		$ 8,050,000
Partial exercise of underwriter's over-allotment option
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of units sold | shares	1,700,000
Units issued aggregate amount	$ 17,000,000

REVISION OF PREVIOUSLY ISSUED_3

REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Schedule of impact of revision on financial statements (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
CONDENSED STATEMENTS OF OPERATIONS
Change in fair value of over-allotment liability							$ 0	$ 196,475
Transaction costs allocable to representative shares							0	(68,476)
Net Loss	$ 1,129,733	$ 2,107,560	$ 1,610,657	$ 3,921,124	$ (2,899,681)	$ (396,332)	4,847,950	753,110
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
Issuance of Representative Shares						3,000,000	870	3,000,000
Remeasurement to amount subject to redemption	1,072,976	265,640				27,918,703		(27,918,703)
Net Loss	1,129,733	2,107,560	1,610,657	3,921,124	(2,899,681)	(396,332)	4,847,950	753,110
CONDENSED STATEMENTS OF CASH FLOWS
Change in fair value of over-allotment liability							0	(196,475)
Transaction costs allocable to representative shares							0	68,476
Net Loss	$ 1,129,733	$ 2,107,560	$ 1,610,657	$ 3,921,124	$ (2,899,681)	$ (396,332)	$ 4,847,950	753,110
Initial classification of over-allotment Liability								294,078
As Previously Reported
CONDENSED STATEMENTS OF OPERATIONS
Change in fair value of over-allotment liability								0
Transaction costs allocable to representative shares								0
Net Loss								625,111
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
Issuance of Representative Shares								870
Remeasurement to amount subject to redemption								(24,791,574)
Net Loss								625,111
CONDENSED STATEMENTS OF CASH FLOWS
Change in fair value of over-allotment liability								0
Transaction costs allocable to representative shares								0
Net Loss								625,111
Initial classification of over-allotment Liability								0
Adjustment
CONDENSED STATEMENTS OF OPERATIONS
Change in fair value of over-allotment liability								196,475
Transaction costs allocable to representative shares								(68,476)
Net Loss								127,999
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
Issuance of Representative Shares								2,999,130
Remeasurement to amount subject to redemption								3,127,129
Net Loss								127,999
CONDENSED STATEMENTS OF CASH FLOWS
Change in fair value of over-allotment liability								(196,475)
Transaction costs allocable to representative shares								68,476
Net Loss								127,999
Initial classification of over-allotment Liability								$ 294,708

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 03, 2021	Mar. 12, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash equivalents	$ 0		$ 0		$ 0
Transaction costs							$ 18,140,741
Other offering costs						$ 705,741	705,741
Sale of stock, other offering costs, temporary equity						234,438
Sale of stock, other offering costs, expensed						471,303
Underwriting fees						6,340,000	6,340,000
Deferred Offering Cost Non Current	$ 11,095,000		$ 11,095,000		11,095,000	$ 11,095,000	$ 11,095,000
Effective Tax Rate	15.24%	0%	6.84%	0%
Statutory federal income tax rate	21%	21%	21%	21%
Unrecognized tax benefits	$ 0		$ 0		0
Unrecognized tax benefits accrued for interest and penalties	$ 0		$ 0		$ 0
Purchase of aggregate shares			8,134,750
Number of dilutive securities	0		0		0

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A common stock reflected in the balance sheet (Details) - Class A common stock subject to redemption - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Gross proceeds		$ 317,000,000
Proceeds allocated to Public Warrants		(7,053,250)
Class A common stock issuance costs		(20,865,453)
Remeasurement to amount subject to redemption	$ 1,338,616	27,918,703
Class A common stock subject to possible redemption	$ 318,338,616	$ 317,000,000

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of calculation of basic and diluted net income (loss) per common share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Class A Common Stock
Numerator:
Allocation of net income, as adjusted	$ 910,100	$ 3,158,811	$ 3,905,452	$ 572,441
Denominator:
Basic weighted average ordinary share outstanding (in shares)	32,839,000	32,839,000	32,839,000	24,779,612
Diluted weighted average ordinary share outstanding (in shares)	32,839,000	32,839,000	32,839,000	24,779,612
Basic net income per ordinary share (in dollars per share)	$ 0.03	$ 0.10	$ 0.12	$ 0.02
Diluted net income per ordinary share (in dollars per share)	$ 0.03	$ 0.10	$ 0.12	$ 0.02
Class B Common Stock
Numerator:
Allocation of net income, as adjusted	$ 219,633	$ 762,313	$ 942,498	$ 180,669
Denominator:
Basic weighted average ordinary share outstanding (in shares)	7,925,000	7,925,000	7,925,000	7,820,696
Diluted weighted average ordinary share outstanding (in shares)	7,925,000	7,925,000	7,925,000	7,820,696
Basic net income per ordinary share (in dollars per share)	$ 0.03	$ 0.10	$ 0.12	$ 0.02
Diluted net income per ordinary share (in dollars per share)	$ 0.03	$ 0.10	$ 0.12	$ 0.02

PUBLIC OFFERING (Details)

PUBLIC OFFERING (Details)	Mar. 12, 2021 $ / shares shares
PUBLIC OFFERING
Purchase price per unit | $ / shares	$ 10
Class A Common Stock
PUBLIC OFFERING
Number of shares in a unit	1
Public Warrants
PUBLIC OFFERING
Number of warrants in a unit (in shares)	0.25
Public Warrants | Class A Common Stock
PUBLIC OFFERING
Number of shares issuable per warrant	1
Exercise price of warrants | $ / shares	$ 11.50
Public offering
PUBLIC OFFERING
Number of units sold	31,700,000
Purchase price per unit | $ / shares	$ 10
Partial Exercise of Underwriter's Over-Allotment Option [Member]
PUBLIC OFFERING
Number of units sold	1,700,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($)		9 Months Ended
	Mar. 12, 2021	Sep. 30, 2022	Sep. 30, 2021	Mar. 31, 2021	Mar. 08, 2021
PRIVATE PLACEMENT
Aggregate purchase price		$ 0	$ 8,390,000
Class A Common Stock
PRIVATE PLACEMENT
Number of shares in a unit	1
Private Placement | Private Placement Units
PRIVATE PLACEMENT
Number of warrants in a unit (in shares)	0.25
Private Placement | Private Placement Units | Class A Common Stock
PRIVATE PLACEMENT
Number of shares in a unit	1
Private Placement | Private Placement Warrants
PRIVATE PLACEMENT
Warrants exercisable to purchase common stock				839,000
Private Placement | Private Placement Warrants | Class A Common Stock
PRIVATE PLACEMENT
Warrants exercisable to purchase common stock	1
Exercise price of warrants	$ 11.50
Sponsor and EarlyBirdCapital | Partial exercise of underwriter's over-allotment option | Private Placement Units
PRIVATE PLACEMENT
Warrants exercisable to purchase common stock	34,000
Aggregate purchase price	$ 340,000
Sponsor and EarlyBirdCapital | Private Placement | Private Placement Units
PRIVATE PLACEMENT
Warrants exercisable to purchase common stock					805,000
Price of warrants (in dollars per share)					$ 10
Sponsor | Over-allotment option | Private Placement Units
PRIVATE PLACEMENT
Warrants exercisable to purchase common stock					67,500
Sponsor | Private Placement | Private Placement Units
PRIVATE PLACEMENT
Warrants exercisable to purchase common stock					655,000
EarlyBirdCapital,Inc. | Over-allotment option | Private Placement Units
PRIVATE PLACEMENT
Warrants exercisable to purchase common stock					22,500
EarlyBirdCapital,Inc. | Private Placement | Private Placement Units
PRIVATE PLACEMENT
Warrants exercisable to purchase common stock					150,000

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details)						3 Months Ended	9 Months Ended
	Mar. 12, 2021 shares	Mar. 03, 2021 shares	Feb. 18, 2021 USD ($) $ / shares shares	Feb. 04, 2021	Nov. 10, 2020 USD ($) shares	Mar. 31, 2021 USD ($)	Sep. 30, 2022 USD ($) D $ / shares shares	Sep. 30, 2021 USD ($)	Dec. 31, 2021 shares
RELATED PARTY TRANSACTIONS
Aggregate purchase price | $						$ 3,000,000	$ 870	$ 3,000,000
Number of shares issued (in shares)							300,000
Class B Common Stock
RELATED PARTY TRANSACTIONS
Common shares, shares outstanding							7,925,000		7,925,000
Sponsor | Class B Common Stock
RELATED PARTY TRANSACTIONS
Stock split ratio		1.2
Sponsor | Class B Common Stock | Independent Directors
RELATED PARTY TRANSACTIONS
Number of shares transferred (in shares)			45,000
Number of shares grant (in shares)		54,000
Sponsor | Class B Common Stock | D. Amsterdam
RELATED PARTY TRANSACTIONS
Number of shares transferred (in shares)			15,000
Number of shares grant (in shares)		18,000
Sponsor | Class B Common Stock | A. Ebush
RELATED PARTY TRANSACTIONS
Number of shares transferred (in shares)			15,000
Number of shares grant (in shares)		18,000
Sponsor | Class B Common Stock | A. Savar
RELATED PARTY TRANSACTIONS
Number of shares transferred (in shares)			15,000
Number of shares grant (in shares)		18,000
Founder Shares
RELATED PARTY TRANSACTIONS
Share, per share | $ / shares			$ 6.91
Total aggregate value of shares | $			$ 373,140
Stock-based compensation expense | $							$ 0
Founder Shares | Class B Common Stock
RELATED PARTY TRANSACTIONS
Stock split ratio		1.2		1.25
Common shares, shares outstanding		8,625,000
Founder Shares | Sponsor
RELATED PARTY TRANSACTIONS
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders	20%
Restrictions on transfer period of time after business combination completion							1 year
Founder Shares | Sponsor | Class B Common Stock
RELATED PARTY TRANSACTIONS
Aggregate purchase price | $					$ 25,000
Number of shares issued (in shares)					5,750,000
Common shares, shares outstanding	7,925,000
Maximum shares subject to forfeiture (in shares)	700,000
Number of shares no longer subject to forfeiture	425,000
Number of shares forfeited	700,000
Founder Shares | Sponsor | Class A Common Stock
RELATED PARTY TRANSACTIONS
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares							$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D							20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D							30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences							150 days

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 08, 2021	Mar. 03, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Nov. 10, 2020
RELATED PARTY TRANSACTIONS
Repayment of promissory note - related party					$ 0	$ 200,000
Administrative Service Agreement
RELATED PARTY TRANSACTIONS
Expenses per month		$ 10,000
Expenses incurred and paid			$ 30,000	$ 30,000	90,000	$ 70,000
Promissory Note with Related Party
RELATED PARTY TRANSACTIONS
Maximum borrowing capacity of related party promissory note								$ 300,000
Outstanding balance of related party note			0		0		$ 0
Repayment of promissory note - related party	$ 200,000
Related Party Loans | Working Capital Loans
RELATED PARTY TRANSACTIONS
Outstanding balance of related party note			0		0		0
Loan conversion agreement warrant			$ 1,500,000		$ 1,500,000
Price of warrant (in dollars per share)			$ 10		$ 10
Accrued expenses | Administrative Service Agreement
RELATED PARTY TRANSACTIONS
Expenses incurred and paid					$ 10,000		$ 10,000

COMMITMENTS (Details)

COMMITMENTS (Details)		9 Months Ended
	Mar. 12, 2021 shares	Sep. 30, 2022 USD ($) item D $ / shares shares
COMMITMENTS
Maximum number of demands for registration of securities | item		1
Underwriting agreement option period granted | D		45
Number of units for which underwriters forfeited their option to purchase	2,800,000
Deferred fee per unit | $ / shares		$ 0.35
Aggregate deferred underwriting fee payable | $		$ 10,500,000
Aggregate deferred underwriting fee Payable on full exercise of over allotment option | $		$ 12,075,000
Over-allotment option
COMMITMENTS
Number of shares granted to underwriters		4,500,000
Partial exercise of underwriter's over-allotment option
COMMITMENTS
Number of units sold	1,700,000

STOCKHOLDERS' DEFICIT - Preferr

STOCKHOLDERS' DEFICIT - Preferred Stock (Details) - $ / shares	Sep. 30, 2022	Dec. 31, 2021	Mar. 08, 2021
STOCKHOLDERS' DEFICIT
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0	0
Preferred shares, shares outstanding	0	0	0

STOCKHOLDERS' DEFICIT - Common

STOCKHOLDERS' DEFICIT - Common Stock (Details)	9 Months Ended
	Sep. 30, 2022 Vote $ / shares shares	Dec. 31, 2021 Vote $ / shares shares
Class of Stock
Ratio to be applied to the stock in the conversion	1
Class A Common Stock
Class of Stock
Common shares, shares authorized (in shares)	100,000,000	100,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Common shares issued, including stocks subject to redemption (in shares)	32,839,000	32,839,000
Common shares outstanding, including stocks subject to redemption (in shares)	32,839,000	32,839,000
Class A common stock subject to redemption
Class of Stock
Class A common stock subject to possible redemption, issued (in shares)	31,700,000	31,700,000
Class A common stock subject to possible redemption, outstanding (in shares)	31,700,000	31,700,000
Class B Common Stock
Class of Stock
Common shares, shares authorized (in shares)	10,000,000	10,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Common shares, votes per share | Vote	1	1
Common shares, shares issued (in shares)	7,925,000	7,925,000
Common shares, shares outstanding (in shares)	7,925,000	7,925,000
Aggregated shares issued upon converted basis (in percent)	20%

WARRANTS (Details)

WARRANTS (Details)	3 Months Ended	9 Months Ended
	Mar. 31, 2021 USD ($)	Sep. 30, 2022 USD ($) D $ / shares shares	Sep. 30, 2021 USD ($)
Class of Warrant or Right
Maximum period after business combination in which to file registration statement		20 days
Issuance of Representative Shares (in shares) | shares		300,000
Issuance of Representative Shares | $	$ 3,000,000	$ 870	$ 3,000,000
Estimated fair value of Representative Shares | $		$ 3,000,000
Warrants
Class of Warrant or Right
Threshold trading days for redemption of warrants | D		20
Share price		$ 9.20
Percentage of gross proceeds on total equity proceeds		50%
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)		115%
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)		180%
Warrants | Class A Common Stock
Class of Warrant or Right
Share price		$ 9.20
Warrants | Redemption of warrants when the price per Class A common stock equals or exceeds $18.00
Class of Warrant or Right
Stock price trigger for redemption of warrants (in dollars per share)		18
Redemption price per warrant (in dollars per share)		$ 0.01
Minimum threshold written notice period for redemption of public warrants		30 days
Redemption period		30 days
Threshold trading days for redemption of warrants | D		20
Threshold consecutive trading days for redemption of warrants | D		30
Threshold number of business days before sending notice of redemption to warrant holders | D		3
Warrants | Redemption of warrants when the price per Class A common stock equals or exceeds $10.00
Class of Warrant or Right
Stock price trigger for redemption of warrants (in dollars per share)		$ 10
Redemption price per warrant (in dollars per share)		$ 0.10
Minimum threshold written notice period for redemption of public warrants		30 days
Redemption period		30 days
Public Warrants
Class of Warrant or Right
Warrant exercise period condition one		30 days
Public Warrants expiration term		5 years
Private Placement Warrants
Class of Warrant or Right
Restrictions on transfer period of time after business combination completion		30 days

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Assets:
Marketable securities held in Trust Account	$ 318,684,239	$ 317,025,510
Liabilities:
Warrant Liability	488,085	4,629,712
Private Placement Warrants
Liabilities:
Warrant Liability	10,000	120,000
Level 1 | Recurring
Assets:
Marketable securities held in Trust Account	318,684,239	317,025,510
Level 1 | Recurring | Public Warrants
Liabilities:
Warrant Liability	475,500	4,510,337
Level 3 | Recurring | Private Placement Warrants
Liabilities:
Warrant Liability	$ 12,585	$ 119,375

FAIR VALUE MEASUREMENTS - Initi

FAIR VALUE MEASUREMENTS - Initial and subsequent measurement of key inputs for Warrants (Details) - Private Placement Warrants	9 Months Ended	12 Months Ended
	Sep. 30, 2022 $ / shares	Dec. 31, 2021 $ / shares
Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Public Warrants and Private Placement Warrants	0.0412	0.0119
Effective expiration date
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivative Liability, Measurement Input	06/06/2024	7/23/2026
Dividend yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Public Warrants and Private Placement Warrants	0	0
Expected volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Public Warrants and Private Placement Warrants	0.064	0.121
Exercise price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Public Warrants and Private Placement Warrants	11.50	11.50
Unit Price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Public Warrants and Private Placement Warrants	9.81	9.71

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]			Change in fair value of warrant liability
Level 3 | Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value beginning balance	$ 14,683	$ 68,904	$ 119,375	$ 253,798	$ 174,903		$ 119,375
Change in fair value	(2,098)	(54,221)	(50,471)	(109,070)	79,705	$ (12,585)
Fair value ending balance	12,585	$ 14,683	$ 68,904	144,728	253,798	174,903	12,585	$ 144,728
Level 3 | Private Placement Warrants | Initial Public Offering
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Issuance of warrants						179,113
Level 3 | Private Placement Warrants | Over-allotment option
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Issuance of warrants						7,565
Level 3 | Public Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Fair value beginning balance					6,577,750
Change in fair value					3,011,500	(475,500)
Transfer from Level 3 to Level 1	$ 0			$ (9,589,250)	$ (9,589,250)		$ 0	$ (9,589,250)
Fair value ending balance						6,577,750
Level 3 | Public Warrants | Initial Public Offering
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Issuance of warrants						6,675,000
Level 3 | Public Warrants | Over-allotment option
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Issuance of warrants						$ 378,250

FAIR VALUE MEASUREMENTS - Addit

FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)		3 Months Ended			9 Months Ended
	Mar. 12, 2021	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Aggregate values of Warrants		$ 488,085			$ 488,085		$ 4,629,712
Class A Common Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Number of shares in a unit	1
Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Number of warrants in a unit (in shares)	0.25
Public Warrants | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Transfers from Level 3		0	$ 9,589,250	$ 9,589,250	0	$ 9,589,250
Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Aggregate values of Warrants		$ 10,000			$ 10,000		$ 120,000